Johnson & Johnson (NYSE: JNJ) is expanding the U.S. roll-out of its latest advancement in presbyopia-correcting intraocular ...

LIMERICK, IRELAND, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Johnson & Johnson MedTech*, a global leader in eye health, announced today that its TECNIS PureSee purely refractive presbyopia-correcting lens is ...

Johnson & Johnson (JNJ) announced on Thursday that the U.S. Food and Drug Administration (FDA) approved its Tecnis PureSee intraocular lens (IOL), giving eye surgeons a new lens option for use in ...

Johnson & Johnson is expanding availability of the presbyopia-correcting Tecnis PureSee IOL in the United States, according ...

New Delhi: Johnson & Johnson (J&J) has introduced the TECNIS PureSee, a purely refractive intraocular lens (IOL) designed for individuals with presbyopia, in India. The TECNIS PureSee IOL delivers ...

Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens (IOL) intended for use in cataract ...

AUSTIN, TX, UNITED STATES, April 2, 2026 /EINPresswire.com/ — Dell Laser Consultants is proud to be among the first practices in the United States to offer the ...

Johnson & Johnson is expanding the US roll-out of its latest advancement in presbyopia-correcting intraocular lenses (PC-IOLs). TECNIS PureSee IOL is an extended depth of focus (EDOF) lens designed to ...